Cellular Determinants of The Radiation Response/RT-Drug Combinations
The RadNet Glasgow+ Discovering Cellular Determinants of the Radiation Response and Developing Novel Radiotherapy-Drug Combinations theme focuses on improving our understanding of how cancer cells respond to radiation at a molecular and cellular level. By identifying the key biological factors that influence sensitivity or resistance to radiotherapy, our researchers aim to uncover new opportunities for targeted intervention. This knowledge supports the development of innovative radiotherapy–drug combinations designed to enhance treatment effectiveness, reduce side effects, and ultimately improve outcomes for people affected by cancer.